DELEX PHARMACY Accelerates Further Expansion with New Branch Opening in Aklan Province,

October 28, 2025 – Delex Pharmacy announced the opening of its fourth branch in Ibajay, Aklan Province, its third in the Western Visayas region, with the inauguration of a new branch in Ibajay, Aklan. The expansion, which commenced operations on September 25, 2025, marks a strategic step in the company's commitment to widening access to affordable and high-quality pharmaceutical products across the Philippines.

The opening was attended by Mr. J. de Ruyter Oroceo, CEO and Chairman of the Board, alongside other senior company officials. The Ibajay, Aklan location reinforces Delex Pharmacy's accelerating growth trajectory and its focus on establishing a robust national footprint.

Founded on October 18, 2021, the company has demonstrated consistent growth since its inception in Quezon City during the pandemic. Delex Pharmacy's strategy centers on locating facilities near critical healthcare hubs to efficiently serve both communities and medical professionals.

The new branch aims to ensure residents of Aklan and surrounding areas have reliable access to safe, effective, and cost-efficient pharmaceutical supplies, directly benefiting the local healthcare ecosystem.

This latest expansion aligns with Delex Pharmacy's core mission to deliver essential healthcare services closer to underserved communities, translating its customer and partner support into concrete market growth and operational milestones.

About Bounce Mobile Systems, Inc. (BNCM)

On July 2^nd. In 2024, the Board of Directors of Bounce Mobile Systems Inc. (BNCM) and Delex Healthcare Group Inc. (DELEX) signed an agreement for the merger between DELEX and BNCM. 

About Delex Healthcare Group Inc. (DELEX)

DELEX is a leading pharmaceutical company in the Philippines, engaged in the development, marketing, and distribution of a wide range of pharmaceutical and healthcare products. DELEX is committed to providing quality and affordable medicines and medical devices, with a strong focus on critical care, anti-infectives, anesthesia, oncology, and women's health.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are based on the current expectations and beliefs of management and are subject to risks and uncertainties. Investors are cautioned that actual results may differ materially from those projected. The statements regarding expected revenue contribution, expansion of pharmacy stores, and international market entry are forward-looking and subject to change.